• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 86 of 100
Key Speakers At The Stanford Institute For Economic Policy Research Forum
HealthSenate Accuses Gilead of Putting Profits Ahead of Hep C Patients
By ReutersDecember 2, 2015
HealthPrediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
By Erika FryDecember 1, 2015
MSMB Capital Management CIO Martin Shkreli
HealthExpress Scripts is Taking on Turing Pharmaceuticals’ 5,000% Price Hike
By Claire GrodenDecember 1, 2015
Pfizer CEO Ian Read
FinancePfizer Says No Merger Tax Help For Our Top Execs
By Dan PrimackNovember 25, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring Offers Hospitals Discounts on Daraprim Price
By Laura LorenzettiNovember 25, 2015
U.S. Multinationals in Puerto Rico
HealthFDA Approves New Eli Lilly Drug for Advanced Lung Cancer
By Laura LorenzettiNovember 24, 2015
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceBill Ackman Just Boosted His Valeant Stake
By ReutersNovember 24, 2015
Pfizer In Merger Talks With Allergan PLC
HealthPfizer, Allergan Confirm $160 Billion Merger Deal
By Geoffrey Smith and Claire GrodenNovember 23, 2015
Pfizer In Merger Talks With Allergan PLC
LeadershipPfizer, Allergan Poised for $150 Billion Merger
By Claire GrodenNovember 22, 2015
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO Blasts Company that Raised Drug Prices 5,000%
By Laura LorenzettiNovember 20, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthAstraZeneca, Sanofi Add New Twist to Pharma Merger Mania
By Reuters and Coins2Day EditorsNovember 20, 2015
MSMB Capital Management CIO Martin Shkreli
FinanceTuring CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
LeadershipA Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By Alan MurrayNovember 19, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
LeadershipThe Treasury Will Crack Down on ‘Tax Inversions’ This Week
By Geoffrey SmithNovember 19, 2015
571977919
HealthGlobal Drug Spending Will Reach $1.4 Trillion by 2020
By Laura LorenzettiNovember 18, 2015
1...
  • 84
  • 85
  • 86
  • 87
  • 88
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.